Clinical Trial

Peripheral Artery Disease in Regular Hemodialysis Patients

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 17, 2025 (before its estimated January 13, 2026 completion). Its status may not reflect the trial's current state.
Summary
Recent studies have reinforced the association between high NLR and PAD in hemodialysis patients. This highlights the need for further studies to confirm its predictive value and determine optimal cut-off thresholds tailored to local patient populations. Accordingly, the present study aims to investigate the relationship between NLR and the presence of PAD in patients undergoing regular hemodialysis. By establishing this association in a well-defined population, we hope to provide evidence that supports the use of NLR as a simple, cost-effective tool for PAD risk stratification and early intervention
Trial Details
NCT Number NCT07179211
Lead Sponsor Sohag University
Conditions Chronic Kidney Disease
Enrollment 120 participants
Start Date 2025-07-13
Primary Completion 2026-01-13 (estimated)
Study Completion 2026-07-13 (estimated)
Updated on ClinicalTrials.gov 2025-09-17